KemPharm, Inc. (Nasdaq: KMPH) announced that the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE